News und Analysen

Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) expects to announce its financial results for the third quarter ended September 30, 2024 after the close of markets on

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) today announced the preliminary results of its substantial issuer bid (the “Offer”), which expired at 5:00 p.m. (Toronto Time) on

Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its wholly owned subsidiary Granite REIT Holdings Limited Partnership (“Granite LP”) has priced an

Granite Real Estate Investment Trust (“Granite REIT”) and Granite REIT Inc. (“Granite GP”) (collectively, “Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that on October 1, 2024 Granite

Regulatory News:

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

Vistagen (Nasdaq: VTGN) a late clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of groundbreaking therapies for psychiatric and

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today that the Corporation has mailed a notice of variation and extension (the “Notice”) in connection with its

Granite Real Estate Investment Trust (“Granite REIT”) and Granite REIT Inc. (“Granite GP” and, together with Granite REIT, “Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that the previously

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today the Corporation is varying the terms of its previously announced substantial issuer bid (the “Offer”). Under the

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today that it has entered into an agreement to sell (the “Offering”) debentures with an aggregate principal amount of

CI Financial Corp. (“CI”) (TSX: CIX) today reported preliminary total assets of $509.2 billion as at August 31, 2024, consisting of asset management assets of $133.1 billion, Canadian wealth

Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.275 per stapled unit for the month of

CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month or quarter ending September 30, 2024 in respect of the CI ETFs. In all cases, the distribution

Fujitec Co., Ltd. (TOKYO:6406) became the first Japanese company to obtain certification for elevator maintenance using remote monitoring. Fujitec acquired this certification, promoted by the

CI Financial Corp. (“CI”) (TSX: CIX) announces that it has asked Morningstar DBRS to withdraw its issuer credit rating and debenture ratings on CI and its debt.

The request is the result of

CI Global Asset Management (“CI GAM”) announces the launch of CI Global Quality Dividend Growth Index Fund and CI Global Quality Dividend Growth Index ETF, which seek to provide exposure to a

CI Global Asset Management (“CI GAM”) today announced a series of significant enhancements to its private markets funds, including eligibility for registered plans and the removal of the lock-up

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today it has commenced a substantial issuer bid (the “Offer”), pursuant to which the Corporation will offer to purchase

CI Financial Corp. (“CI”) (TSX: CIX) today reported preliminary total assets of $511.3 billion as at July 31, 2024, consisting of asset management assets of $133.3 billion, Canadian wealth

Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.275 per stapled unit for the month of

CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending August 31, 2024 in respect of the CI ETFs. In all cases, the distribution will be paid

Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for

Vistagen (Nasdaq: VTGN), a late clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of groundbreaking therapies for psychiatric and